Leupe, H.; Cauwenbergh, M.; Cleeren, F.; Dekervel, J.; Verslype, C.; Deroose, C.M.
Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors. Pharmaceuticals 2025, 18, 1608.
https://doi.org/10.3390/ph18111608
AMA Style
Leupe H, Cauwenbergh M, Cleeren F, Dekervel J, Verslype C, Deroose CM.
Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors. Pharmaceuticals. 2025; 18(11):1608.
https://doi.org/10.3390/ph18111608
Chicago/Turabian Style
Leupe, Hannes, Merel Cauwenbergh, Frederik Cleeren, Jeroen Dekervel, Chris Verslype, and Christophe M. Deroose.
2025. "Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors" Pharmaceuticals 18, no. 11: 1608.
https://doi.org/10.3390/ph18111608
APA Style
Leupe, H., Cauwenbergh, M., Cleeren, F., Dekervel, J., Verslype, C., & Deroose, C. M.
(2025). Clinical Experience with Targeted Alpha-Emitter Peptide Receptor Radionuclide Therapy (α-PRRT) for Somatostatin Receptor-Positive Neuroendocrine Tumors. Pharmaceuticals, 18(11), 1608.
https://doi.org/10.3390/ph18111608